The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits false or misleading advertisements related to drugs or magic remedies. It defines terms like "drug" and "advertisement" and sets rules around advertising drugs for conditions like miscarriage or sexual pleasure. The Act establishes penalties for violations and gives powers to authorize officers to inspect and seize non-compliant advertisements. It aims to protect consumers from objectionable or misleading claims in drug advertising.
The prevention of cruelty to animals act 1960Shaik Rasheed
This presentation give the complete information regarding the The Prevention of Cruelty to Animals Act 1960 including the definitions, composition of IAEC, Breeding and stocking of animals, experiments, offences and penalties.
The Drugs and Cosmetics Act, 1940 is an Act of the Parliament of India which regulates the import, manufacture and distribution of drugs in India. The primary objective of the act is to ensure that the drugs and cosmetics sold in India are safe, effective and conform to state quality standards.
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Sagar Savale
An Act to control the advertisement of drugs in certain cases, to prohibit the advertisement for certain purposes of remedies alleged to possess magic qualities and to provide for matters connected therewith. This act is not unconstitutional, because it does not interferes with private business and also it does not impose unreasonable restrictions.
This presentation includes an brief idea about the pharmacy act 1948 in India and also deals with its the chapter that included in the act.(Education Regulations, PCI, State PCI, Registration of Pharmacist , Approval of Institutions, Offences penalties etc.)
The prevention of cruelty to animals act 1960Shaik Rasheed
This presentation give the complete information regarding the The Prevention of Cruelty to Animals Act 1960 including the definitions, composition of IAEC, Breeding and stocking of animals, experiments, offences and penalties.
The Drugs and Cosmetics Act, 1940 is an Act of the Parliament of India which regulates the import, manufacture and distribution of drugs in India. The primary objective of the act is to ensure that the drugs and cosmetics sold in India are safe, effective and conform to state quality standards.
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Sagar Savale
An Act to control the advertisement of drugs in certain cases, to prohibit the advertisement for certain purposes of remedies alleged to possess magic qualities and to provide for matters connected therewith. This act is not unconstitutional, because it does not interferes with private business and also it does not impose unreasonable restrictions.
This presentation includes an brief idea about the pharmacy act 1948 in India and also deals with its the chapter that included in the act.(Education Regulations, PCI, State PCI, Registration of Pharmacist , Approval of Institutions, Offences penalties etc.)
The Drugs and Magic Remedies (Objectionable Advertisements) Act is an Act No. 21 of 1954, which came in force on 1st of April 1955.
AIM: To control the Ad. Of drugs in certain cases, to prohibit the ads. For certain purposes for remedies alleged to possess magic qualities & to provide for related matters
Codes of pharmaceutical ethics
In relation to his trade
In relation to his Job
In relation to his Profession
In relation to Medical Profession
Pharmacist's Oath
At the end of the 19th century and early 20 century use of Allopathy system increases
Drugs of natural origin: Veg, mineral oil and animals
At that time, profit became main motive than service
Overdose of quinine.A Central law to control drugs and pharmacy profession.
This act gives an idea about the constitution and functions of PCI. Brief about Education Regulation in India. Registration procedure for the pharmacist in India.
Medicinal and toilet preparations act and rules,1955Ganesh Shevalkar
It is an Act with provision for levy and collection of excise duties on medicinal and toilet preparations containing alcohol, opium, Indian hemp (cannabis) or other narcotic drugs.
A presentation aimed at providing information with regards to the Pharmacy Act, 1948.
-INTRODUCTION
-HISTORY OF THE ACT
-PHARMACY COUNCIL OF INDIA
-STATE PHARMACY COUNCIL
-SPECIAL PROVISIONS OF THE ACT
-OFFENCES AND PENALTIES
-CONCLUSION
-REFERENCES
This presentation is related to the drug price control order in India. It will give an idea to the readers how the prices have been fixed for the formulations. How the price has been calculated for scheduled formulations.
These presentation describes the rules and regulations for the manufacture of drugs and grant of license. Loan License and Repacking License is also described. These presentation is the part of series Drugs & Cosmetics Act.
The Drugs and Magic Remedies (Objectionable Advertisements) Act is an Act No. 21 of 1954, which came in force on 1st of April 1955.
AIM: To control the Ad. Of drugs in certain cases, to prohibit the ads. For certain purposes for remedies alleged to possess magic qualities & to provide for related matters
Codes of pharmaceutical ethics
In relation to his trade
In relation to his Job
In relation to his Profession
In relation to Medical Profession
Pharmacist's Oath
At the end of the 19th century and early 20 century use of Allopathy system increases
Drugs of natural origin: Veg, mineral oil and animals
At that time, profit became main motive than service
Overdose of quinine.A Central law to control drugs and pharmacy profession.
This act gives an idea about the constitution and functions of PCI. Brief about Education Regulation in India. Registration procedure for the pharmacist in India.
Medicinal and toilet preparations act and rules,1955Ganesh Shevalkar
It is an Act with provision for levy and collection of excise duties on medicinal and toilet preparations containing alcohol, opium, Indian hemp (cannabis) or other narcotic drugs.
A presentation aimed at providing information with regards to the Pharmacy Act, 1948.
-INTRODUCTION
-HISTORY OF THE ACT
-PHARMACY COUNCIL OF INDIA
-STATE PHARMACY COUNCIL
-SPECIAL PROVISIONS OF THE ACT
-OFFENCES AND PENALTIES
-CONCLUSION
-REFERENCES
This presentation is related to the drug price control order in India. It will give an idea to the readers how the prices have been fixed for the formulations. How the price has been calculated for scheduled formulations.
These presentation describes the rules and regulations for the manufacture of drugs and grant of license. Loan License and Repacking License is also described. These presentation is the part of series Drugs & Cosmetics Act.
NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACT (NDPS), 1985 WITH RULE Sagar Savale
The Central Acts like Opium Act, 1857,the Opium Act ,1878 and the Dangerous Drugs Act,1930 were enacted a long time ago. With the changing circumstances and the developments in the field illicit drug traffic and drug abuse at national and international level ,many drawbacks have come to notice in the said Acts.
The Government of India has repealed these old Acts and passed “The Narcotic Drugs and Psychotropic Substances Act,1985’’.
These Acts established in 14 November 1985.
Piacenza, October 15, 2011
"Innovating Food, Innovating the Law"
Conference
VINOD KUMAR GUPTA (Traditional Knowledge Digital Library, India)
TKDL as a Model for Protection of Traditional Knowledge and for Rewarding the Creativity in Traditional Knowledge
Video: http://vimeo.com/31475922
important methods employed in quality control of ayurvedic drugsDhanya Renjith
the different methods employed these days to test the quality of ayurvedic drugs is summarised in the presentation. the presentation aims to give an awareness about basic procedures in quality control of ayurvedic drugs.
Drug and magic remedies (objectionable advertisement) act 1954 and rules 1955Dr. Ambekar Abdul Wahid
Definitions, Class of Prohibitions Advertisement - Section 3, Classes of exempted advertisements, Powers of entry, search etc., Offenses and penalties, Scrutiny of misleading advertisements relating to drugs, Manner in which advertisements may be sent confidentially, Case Studies.
India on Sale - Analysis of Biotechnology Regulatory Authority Bill (BRAI)Burning Brain Society
Analysis of Biotechnology Regulatory Authority Bill (BRAI):: The issue is not limited to Bt Brinjal or Bt bacteria alone, the Part I - Schedule I of the proposed legislation also allows the companies to make genetically modified animals and even Clones of animals. Despite such serious implications, there is no punishment prescribed if someone violates the provisions of clinical trial as provided in part I. neither is there any safeguard or liability clause provided. Clearly the bill has been written by the Corporate and not the Government. It looks like that our ministers have not even read the bill.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
2. The Drugs and Magic Remedies (Objectionable
Advertisements) Act is an Act No. 21 of 1954,
which came in force on 1st of April 1955.
The Drugs and Magic Remedies (Objectionable
Advertisements) Rules, 1955.
3. The Drugs and Magic Remedies
(Objectionable Advertisements)
Act, 1954
4. Structure of the act
Section Contents
1 Short title, extent &
Commencement
2 Definitions
3,4,5,6 Prohibitions
7 Power of entry, search etc
8
8 A
Offences by companies
Offences to be cognizable
9 Jurisdiction to try offences
10 Officers to be deemed to be
public servants
5. Structure of the act
Section Contents
11 Indemnity
12 Other laws not affected
13 Savings
14 Power to exempt from
application of act
15 Power to make rules
16 Penalty
6. The Drugs and Magic Remedies (Objectionable
Advertisements) Act, 1954 is an Act No. 21 of
1954
(Section 1)
It extends to the whole of India, except the state
of Jammu & Kashmir.
It was came into force by Gazette notification
on 1st April, 1955.
7. Definitions
‘drug’ includes –
(¡) A medicine for the internal or external use
of human beings or animals;
(¡ ¡) Any substance intended to be used for or in
the diagnostic, cure, mitigation , treatment or
prevention of disease in human beings or
animals;
8. Definitions
‘drug’ includes –
(¡¡¡) Any article, other than food, intended to
affect or influence in any way the structure or
any organic function of the body of human
beings or animals;
(¡v)Any article intended for use as a component
of any medicine, substance or article, referred
to in sub-clauses (i), (i) and (iii);
9. Definitions- D & C act
“drug” includes—
(i) all medicines for internal or external use of human beings or
animals and all substances intended to be used for or in the
diagnosis, treatment, mitigation or prevention of any disease or
disorder in human beings or animals, including preparations
applied on human body for the purpose of repelling insects like
mosquitoes;
(ii) such substances (other than food) intended to affect the
structure or any function of human body or intended to be
used for the destruction of vermin or insects which cause
disease in human beings or animals, as may be specified from
time to time by the Central Government by notification in the
Official Gazette;]
10. Definitions- D & C act
(iii) all substances intended for use as components of a drug
including empty gelatin capsules; and
(iv) such devices intended for internal or external use in the
diagnosis, treatment, mitigation or prevention of disease or
disorder in human beings or animals, as may be specified
from time to time by the Central Government by notification
in the Official Gazette, after consultation with the Board
11. Definitions
‘magic remedy’ includes
A talisman, mantra, kavacha and any other
charm of any kind which is alleged to possess
miraculous powers for or in the diagnosis,
cure, mitigation, treatment or prevention of
any disease in human beings or animals or for
affecting or influencing in any way the
structure or any organic function of the body
of human beings or animals;
13. Definitions
‘Taking any part in the publication of any
advertisement’ includes -
(i) the printing of the advertisement;
(ii) the publication of any advertisement
outside the territories to which this Act
extends by or at the instance of a person
residing within the said territories;
14. PROHIBITIONS -Section 3
Subject to the provisions of this Act, no person
shall take any part in the publication of any
advertisement referring to any drug in terms
which suggest or are calculated to lead to the
use of that drug for –
(a) the procurement of miscarriage in women or
prevention of conception in women; or
(b) the maintenance or improvement of the
capacity of human beings for sexual pleasure; or
(c) the correction of menstrual disorder in
women; or
15. (d) the diagnosis, cure, mitigation, treatment or
prevention of any disease, disorder or condition
specified in the Schedule, or any other disease,
disorder or condition (by whatsoever name
called) which may be specified in the rules made
under this Act.
PROHIBITIONS -Section 3
16. Provided that no such rules shall be made except –
(i) in respect of any disease, disorder or condition which
requires timely treatment in consultation with a
registered medical practitioner or for which there are
normally no accepted remedies, and
(ii) after consultation with the Drug Technical Advisory
Board constituted under the Drugs and Cosmetics Act,
1940 and, if the Central Government considers
necessary, with such order persons having special
knowledge or practical experience in respect of
Ayurvedic or Unani systems of medicines as that
Government deems fit.
17. PROHIBITION OF MISLEADING ADVERTISEMENTS RELATING TO
DRUGS
Subject to the provisions of this Act, no person shall take any part
in the publication of any advertisement relating to a drug if the
advertisement contains any matter which –
(a) directly or indirectly gives a false impression
regarding the true character of the drug; or
(b) make a false claim for the drug; or
(c) is otherwise false or misleading in any material
particular.
18. PROHIBITION OF ADVERTISEMENT OF MAGIC REMEDIES
FOR TREATMENT OF CERTAIN DISEASES AND DISORDERS
No person carrying on or purporting to carry on
the profession of administering magic remedies
shall take any part in the publication of any
advertisement referring to any magic remedy
which directly or indirectly claims to be
efficacious for any of the purpose specified in
Section 3.
19. PROHIBITION OF IMPORT INTO, AND EXPORT FROM
INDIA OF CERTAIN ADVERTISEMENTS
No person shall import into, or export from, the
territories to which this Act extends any document
containing an advertisement of the nature referred to in
Section 3, or Section 4, or Section 5, and any documents
containing any such advertisement shall be deemed to
be goods of which the import or export has been
prohibited under Section 19 of the Sea Customs Act,
1878 and all the provisions of that Act shall have effect
accordingly.
20. Powers Of Entry, Search etc
(1) Subject to the provisions of any rules made in this behalf, any
Gazetted officer authorised by the state Government may, within
the local limits of the area for which he is so authorised –
a) enter and search at all reasonable times, with such
assistants, if any, as he considers necessary, any place in
which he has reason to believe that an offence under this
act has been or is being commited;
b) seize any advertisement which he has reason to believe
contravenes any of provisions of this act;
21. Powers Of Entry, Search etc
c) Examine any record, register, document or any other
material object found in any place mentioned in clause
(a) and seize the same if he has reason to believe that it
may furnish evidence of the commission of an offence
punishable under this act.
(2) Provisions of the code of criminal procedure, 1898 shall
may apply to any search under this act.
(3) Where any person seizes anything under clause (b) or
clause (c) of sub section (1), he shall, as soon as may be
inform a Magistrate and take his orders as to the custody
thereof.
22. Offences By Companies
(1)If the person contravening any of the provisions of this Act is a
company, every person who, at the time the offence was
committed, was in charge of, and was responsible to, the
company for the conduct of the business of the company as well
as the company shall be deemed to be guilty of the
contravention and shall be liable to be proceeded against and
punished accordingly:
(2) Not withstanding anything contained in sub-section (1) where
an offence under this act has been committed by a company and
it is proved that the offence was committed with the consent or
connivance of, or is attributable to any neglect on the part of, any
director or manager, secretary or other officer of the company,
such director manager, secretary or other officer of the company
shall also be deemed to be guilty of that offence and shall be
liable to be proceeded against and punished accordingly.
23. Jurisdiction To Try Offences
No court inferior to that of a Presidency Magistrate or a
Magistrate of first class shall try any offence punishable
under this Act.
Forfeiture
Where a person has been convicted by any court for
contravening any provision of this Act or any rule made
there under, the court may direct that any document
(including all copies thereof), article or thing, in respect
of which the contravention is made, including the
contents thereof where such contents are seized under
clause (b) of sub-section (1) of section 8, shall be
forfeited to the Government.
24. Officers to be deemed to be public servants
Every person authorized under section 8, shall be
deemed to be a public servant within the meaning of
section 21 of Indian Penal Code.
Indemnity
No suit, persecution or other legal proceeding shall lie
against any person for anything which is in good faith
done or intended to be done under this Act.
Other laws not affected
The provisions of this Act in addition to, and not in
derogation of, the provisions of any other law for the
time being in force.
25. SAVINGS – NOTHING IN THIS ACT SHALL APPLY TO :
(a) any signboard or notice displayed by a registered
medical practitioner on his premises indicating that
treatment for any disease, disorder or condition
specified in Section 3, the Schedule or the rules made
under this Act, is undertaken in those premises; or
(b) any treatise or book dealing with any of the matters
specified in Section 3 from a bonafide scientific or
social standpoint; or
(c) any advertisement relating to any drug sent
confidentially in the manner prescribed under Section
16 only to a registered medical practitioner; or
26. SAVINGS – NOTHING IN THIS ACT SHALL APPLY TO :
(d) any advertisement relating to a drug printed or
published by the Government; or
(e) any advertisement relating to a drug printed or
published by any person with the previous sanction of
the Government granted prior to the commencement
of the Drugs and Magic Remedies (Objectionable
Advertisement) Amendment Act, 1963 (42 of 1963);
27. POWER TO EXEMPT FROM APPLICATION OF ACT
If in the opinion of the Central Government public
interest requires that the advertisement of any specified
drug or class of drugs 1[or any specified class of
advertisements relating to drugs] should be permitted; it
may, by notification in the Official Gazzette, direct that
the provisions of sections 3, 4, 5 and 6 or any one of
such provisions shall not apply or shall apply subject to
such conditions as may be specified in the notification to
or in relation to the advertisement of any such drug or
class of drugs 1[or any specified class of advertisement
relating to drugs].
28. POWER TO MAKE RULES
(1) The Central Government may, by notification in the
Official Gazzette, make rules for carrying out the
purposes of this Act.
(2) In particular and without prejudice to the generality of
the foregoing power, such rules may-
(a) specify any [disease, disorder or condition] to which
the provisions of section 3 shall apply;
(b) prescribe the manner in which advertisements of
articles or things referred to in clause (c) of section 14
may be sent confidentially.
29. POWER TO MAKE RULES
(3)Every rule made under this Act shall be laid as soon as
may be after it is made, before each House of Parliament
while it is in session for a total period of thirty days which
may be comprised in one session or in two or more
successive sessions and if before the expiry of session in
which it is so laid or the successive sessions aforesaid,
both Houses agree in making any modification in the rule
or both Houses agree that the rule should not be made,
the rule shall thereafter have effect only in such modified
form or be of no effect, as the case may be; so, however,
that any such modification or annulment shall be without
prejudice to the validity of anything previously done
under that rule.
30. PENALTY
Whoever contravenes any of the provisions of this Act [or
the rules made there under] shall, on conviction, be
punishable –
a) in the case of a first conviction, with
imprisonment which may extend to six months or
with fine, or with both;
b) in the case of a subsequent conviction, with
imprisonment which may extend to one year, or
with fine, or with both.
31. The Drugs and Magic Remedies
(Objectionable Advertisements)
Rules, 1955.
32. Structure of the rule
Rule Content
1 Short title & Commencement
2 Definitions
3 Scrutiny of misleading misleading advertisements relating
to drugs
4 Procedure to be followed in prohibiting import into &
export from, India of certain advertisements
5 Manner in which advertisements may be sent
confidentially
6 Prohibition of advertisement of drugs for treatment of
disease, etc
33. SCRUTINY OF MISLEADING ADVERTISEMENTS
RELATING TO DRUGS
Any person authorised by the state Government in this
behalf may, if satisfied, that an advertisement relating to
a drug contravenes the provisions of section 1 by order,
require the manufacturer , packer, distributer or seller of
the drug to furnish within such time as may be allowed
in this behalf by the person so authorised information
regarding the composition of the drug or the ingredients
thereof or any other information in regard to that drug
as he deems necessary for holding the scrutiny of the
advertisement, and where any such the drug to which
the advertisement relates to comply with the order.
34. SCRUTINY OF MISLEADING ADVERTISEMENTS
RELATING TO DRUGS
Provided that no publisher or advertising agency of any
medium for the dissemination of an advertisement
elating to a drug shall be deemed to have made any
such contravention merely by reason of the
dissemination by him or it of any such advertisement,
unless such publisher or advertising agency has failed
to comply with any direction made by the authorised
person in this behalf calling upon him or it to furnish
the name and address of the manufacturer,
packer,distributer, seller or advertising agency, as the
case may be, who or which caused such advertisement
to be disseminated.
35. PROCEDURE TO BE FOLLOWED IN PROHIBITING IMPORT INTO &
EXPORT FROM, INDIA OF CERTAIN ADVERTISEMENTS
(1)If the customs collector has reasons to believe that any
consignment contains documents of the nature referred
to in section 6, he may , and if requested by an officer
appointed for the purposes by the Central Government,
shall detain the consignment and dispose it of in
accordance with the provisions of the Sea Customs Act
1878 and shall also inform the importer or exporter of
the order so passed.
36. MANNER IN WHICH ADVERTISEMENTS MAY BE SENT
CONFIDENTIALLY
All documents containing advertisements relating to
drugs referred to in clause (c) of sub –section (1) of
section 14, shall be sent by post to a registered medical
practitioner by name, or to a wholesale or retail chemist,
the address of such registered medical practitioner or
wholesaler or retail chemist being given. Such document
shall be at the top, printed in indelible ink in a
conspicuous manner, the words “For the use only of
registered medical practitioners or a hospital or a
laboratory.
37. PROHIBITION OF ADVERTISEMENT OF DRUGS
FOR TREATMENT OF DISEASE, ETC
No person shall also take part in the publication of
any advertisement referring to any drug in terms
which suggest or are calculated to lead to the use of
that drug for the diagnosis,cure,mitigation,treatment
or prevention of any disease, disorder or condition
specified in the Schedule annexed to these rule.
38. REFERENCES
• A Textbook of Forensic Pharmacy, by B.M.
Mithal, Vallabh Prakashan, page no.144-156
• Pharmaceutical Jurisprudence, by B.S.
Kuchekar, Nirali Prakashan, page no.171-176